Empirical Study of Anti-Inflammatory Effects of Kecombrang (Etlingera elatior) in Mus musculus Sepsis Model

Authors

  • Evi Nurhayatun Doctoral Program of Medical Sciences, Faculty of Medicine, Sebelas Maret University, Surakarta, Indonesia https://orcid.org/0000-0002-6267-8103
  • Bambang Purwanto Doctoral Program of Medical Sciences, Faculty of Medicine, Sebelas Maret University, Surakarta, Indonesia
  • Soetrisno Soetrisno Doctoral Program of Medical Sciences, Faculty of Medicine, Sebelas Maret University, Surakarta, Indonesia
  • Dono Indarto Doctoral Program of Medical Sciences, Faculty of Medicine, Sebelas Maret University, Surakarta, Indonesia
  • Eti Poncorini Doctoral Program of Medical Sciences, Faculty of Medicine, Sebelas Maret University, Surakarta, Indonesia
  • Tatar Sumandjar Department of Internal Medicine, Dr. Moewardi General Hospital, Surakarta, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2022.9595

Keywords:

Kecombrang, Caspase 3, Interleukin-1ß, Nuclear factor-kB, Sepsis

Abstract

Mice used as experimental animals in the laboratory belong to the genus Mus, subfamily Murinae, family Muridae, superfamily Muroidea, order Rodentia, and class

M. musculus

, these mice are also referred to as home mice. Mice have been used as standard animals in toxicology, teratology, and carcinogenesis tests, even today, mice have also been used for behavioral, neurologic, nutritional, genetic, immunological, infectious, metabolic, and degenerative disease studies. Animal models of sepsis with intraperitoneal or intravenous injection of lipopolysaccharide (LPS) have been widely used for sepsis research. LPS induces systemic inflammation that mimics the early phase of sepsis. LPS injection causes kidney injury, including a decrease in glomerular filtration rate, an increase in blood urea nitrogen, and an increase in neutrophil infiltration in the kidney. The injectable dose of LPS can be titrated to mimic early sepsis without hemodynamic compromise, which has been useful for studying the systemic and renal responses. The response during the early phase of sepsis is that doses of LPS are usually used to induce systemic hypotension and decrease glomerular perfusion, whereas low doses of LPS do not cause systemic hypotension but still decrease glomerular perfusion. There are several advantages of LPS compared to others, namely, the method used is simple and the model is very controlled and standardized. The dose of endotoxin that causes 50% mortality in mice is 1–25 mg/kg. In this study, mice were given intraperitoneal injection of LPS at a dose of 0.3 mg/kg BW. LPS injection was given to the positive control group and treatment group 1, treatment group 2, and treatment group 3 at the start of the study.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Gyawali B, Ramakrishna K, dan Dhamoon AS. Sepsis: The evolution in definition, pathophysiology, and management. SAGE Open Med. 2019;7:2050312119835043. https://doi.org/10.1177/2050312119835043 PMid:30915218 DOI: https://doi.org/10.1177/2050312119835043

Siddharth D, Chirag C, Abhijit D. Sepsis and septic shock: Guideline-based management. Cleve Clin J Med. 2020;87(1):53-64. https://doi.org/10.3949/ccjm.87a.18143 PMid:31990655 DOI: https://doi.org/10.3949/ccjm.87a.18143

Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, et al. The third international concesus definitions for Sepsis and Septic shock. JAMA. 2016;315(8):801-10. https://doi.org/10.1001/jama.2016.0287 PMid:26903338 DOI: https://doi.org/10.1001/jama.2016.0287

Samarang S, Isnawati R, Murni M. Potensi kandungan karondo (Etlingera elatior) sebagai obat cacing tradisional masyarakat kulawidi sulawesi tengah. J Penyakit Bersumber Binatang. 2020;2(2):1-8.

Howell MD, Davis AM. Management of sepsis and septic shoc. JAMA. 2017;317(8):847-8. https://doi.org/10.1001/jama.2017.0131 PMid:28114603 DOI: https://doi.org/10.1001/jama.2017.0131

Liu SF, dan Malik AB. NF-κB activation as a pathological mechanism of septic shock and inflammation. Am J Physiol Lung Cell Mol. 2020;290:L662-645 https://doi.org/10.1152/ajplung.00477.2005 PMid:16531564 DOI: https://doi.org/10.1152/ajplung.00477.2005

Wu F, Schuster DP, Tyml K, Wilson JX. Ascorbate inhibits NADPH oxidase subunit p47 phox expression in microvascular endothelial cells. Free Radic Biol Med. 2007;42(1):124-31. https://doi.org/10.1016/j.freeradbiomed.2006.10.033 PMid:17157199 DOI: https://doi.org/10.1016/j.freeradbiomed.2006.10.033

Chousterman BG, Swirski FK, dan Weber GF. Cytokinestormand sepsis diseasepathogenesis. Semin Immunopathol. 2017;39(5):517-28. https://doi.org/10.1007/s00281-017-0639-8 PMid:28555385 DOI: https://doi.org/10.1007/s00281-017-0639-8

Satpute MS, Gangan VD, Hastri I. Synthesis and antibacterial activity of novel vanillic acid hybrid derivatives. Rasayan J Chem. 2019;12(1):383-8. https://doi.org/10.31788/rjc.2019.1215023 DOI: https://doi.org/10.31788/RJC.2019.1215023

Sahidin S, Salsabila S, Wahyuni W, Fristiohady A, Imran I. Potensi antibakteri ekstrak metanol dan senyawa aromatik dari buah wualae (Etlingera elatior). J Kimia Valensi. 2019;5(1):1-7. https://doi.org/10.15408/jkv.v5i1.8658 DOI: https://doi.org/10.15408/jkv.v5i1.8658

Vinothiya K, Ashokkumar N. Modulatory effectof vanillic acid on antioxidant status in high fat diet-induced changes in diabetic hypertensiverats. Biomed Pharmacother. 2017;87:640-52. https://doi.org/10.1016/j.biopha.2016.12.134 PMid:28088113 DOI: https://doi.org/10.1016/j.biopha.2016.12.134

Fristiohadya A, Wahyunia W, Ilyas M, Bafadala M, Purnamaa LO, Sangadjia S, et al. Nephroprotective effect of extract Etlingeraelatior (Jack) R.M. Smith on CCl4-induced nephrotoxicity in rats. Curr Res Biosci Biotechnol. 2020;1(2):62-5. https://doi.org/10.5614/crbb.2019.1.2/dapm6106 DOI: https://doi.org/10.5614/crbb.2019.1.2/DAPM6106

Mai CW, Wong SY, Tan EL, Balijepalli MK,Pichika MR. Antiproliferative and apoptotic studies of the standardized extracts of Etlingera elatioron human colorectal carcinomacells. Malays. J Chem. 2009;11:136-42.

Gotts JE, Matthay MA. Sepsis: Pathophysiology and clinical management. BMJ. 2016;353:i1585. https://doi.org/10.1136/bmj.i1585 PMid:27217054 DOI: https://doi.org/10.1136/bmj.i1585

Mera S, Tatulescu D, Cismaru C, Bondor C, Slavcovici A, Zanc V, et al. Multiplex cytokine profiling in patients with sepsis. APMIS. 2010;119(2):155-63. https://doi.org/10.1111/j.1600-0463.2010.02705.x PMid:21208283 DOI: https://doi.org/10.1111/j.1600-0463.2010.02705.x

Bernard GR, Vincent JL, Laterre PF, LaRosa S, Dhainaut JP, Rodriguez AL, et al. Efficacy and safety of recombinant human activated protein C forsevere sepsis. N Eng J Med. 2001;344(10):699-709. https://doi.org/10.1056/nejm200103083441001 PMid:11236773 DOI: https://doi.org/10.1056/NEJM200103083441001

Meng J, Zhang C. Modulating effects of vanillic acid on sepsis-induced oxidative liver injury in rat model. Int J Pharmacol. 2019;15(6):752-8. https://doi.org/10.3923/ijp.2019.752.758 DOI: https://doi.org/10.3923/ijp.2019.752.758

Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving sepsis campaign: International guidelines for management of sepsis andseptic shock: 2016. Intensive Care Med. 2017;43(3):304-77. https://doi.org/10.1007/s00134-008-1090-z PMid:28101605 DOI: https://doi.org/10.1007/s00134-008-1090-z

Downloads

Published

2022-07-29

How to Cite

1.
Nurhayatun E, Purwanto B, Soetrisno S, Indarto D, Poncorini E, Sumandjar T. Empirical Study of Anti-Inflammatory Effects of Kecombrang (Etlingera elatior) in Mus musculus Sepsis Model. Open Access Maced J Med Sci [Internet]. 2022 Jul. 29 [cited 2024 Feb. 25];10(G):682-8. Available from: https://oamjms.eu/index.php/mjms/article/view/9595

Issue

Section

Nursing in Internal Medicine

Categories

Most read articles by the same author(s)

1 2 > >>